Abstract
Background
As diagnosis of nasopharyngeal carcinoma at an early disease stage is important, we attempted to distinguish between patients with nasopharyngeal carcinoma and noncancer controls by using serum protein profiles.
Methods
Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and CM10 protein chip were used to detect the serum proteomic patterns of 65 patients with nasopharyngeal carcinoma before radiotherapy and 93 noncancer controls. Proteomic spectra of serum samples from 50 nasopharyngeal carcinoma patients and 60 noncancer controls were used as a training set. The validity of the classification tree was then challenged with a blind test set which included another 15 patients with nasopharyngeal carcinoma and 33 noncancer controls. Biomarker Wizard 3.01 and Biomarker Pattern 5.01 were used in combination to analyze the data and to develop diagnostic models.
Results
21 protein peaks were significantly different between nasopharyngeal carcinoma and controls. 4 mass peaks (M4182, M5343, M5913 and M8702 mass/charge ratio) were chosen automatically to construct a classification tree. The classification tree correctly determined 93.8 % (45/48) of the test samples with 93.3 % (14/15) of the nasopharyngeal carcinoma samples and 93.9 % (31/33) of the noncancer samples. Using a combination of serum protein profiles and Epstein−Barr viral capsid antigen immunoglobulin A antibody tests, the diagnostic sensitivity and specificity were increased to 100 and 97 %, respectively.
Conclusions
Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry could correctly distinguish nasopharyngeal carcinoma from noncancer individuals and showed great potential for the development of a screening test for the detection of nasopharyngeal carcinoma.
Similar content being viewed by others
References
Wei WI, Sham JST (2005) Nasopharyngeal carcinoma. Lancet 365:2041–2054
Ho JH (1972) Nasopharyngeal carcinoma (NPC). Adv Cancer Res 15:57–92
Teo P, Yu P, Lee WY et al (1996) Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys 36:291–304
Zeng Y, Zhong JM, Li LY et al (1983) Follow-up studies on Epstein-Barr virus IgA/VCA antibody-positive persons in Zangwu County, China. Intervirology 20:190–194
Welsh JB, Sapinoso LM, Kern SG et al (2003) Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc Natl Acad Sci USA 100:3410–3415
Wu CC, Chien KY, Tsang NM et al (2005) Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model. Proteomics 5:3173–3182
Wang Q, Zhang W, Li DR et al (2008) Identification of two potential serum biomarkers for ovarian cancer and clinical validation thereof. Zhonghua Yi Xue Za Zhi 88:1012–1016
Yoshizaki T, Ito M, Murono S et al (2012) Current understanding and management of nasopharyngeal carcinoma. Auris Nasus Larynx 39:137–144
Lin XP, Zhao C, Chen MY et al (2008) Role of 18F-FDG PET/CT in diagnosis and staging of nasopharyngeal carcinoma. Chin J Cancer 27:974–978
Wang GH, Lau EW, Shakher R et al (2007) Clinical application of (18)F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma. Chin J Cancer 26:638–642
Zhang GY, Hu WH, Liu LZ et al (2006) Comparison between PET/CT and MRI in diagnosing lymph node metastasis and N staging of nasopharyngeal carcinoma. Chin J Oncol 28:381–384
Seibert V, Wiesner A, Buschmann T et al (2004) Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI TOF-MS) and ProteinChip technology in proteomics research. Pathol Res Pract 200:83–94
Jain KK (2007) Recent advances in clinical oncoproteomics. J BUON 12(Suppl 1):S31–S38
Qian JY, Mou SH, Liu CB (2012) SELDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of a boosting decision tree model for diagnosis of pancreatic cancer. Asian Pac J Cancer P 13:1911–1915
Zhang K, Yuan K, Wu H et al (2012) Identification of potential markers related to neoadjuvant chemotherapy sensitivity of breast cancer by SELDI-TOF MS. Appl Biochem Biotech 166:753–763
Cao SM, Yu JK, Chen QY et al (2010) Detection of nasopharyngeal carcinoma using surface-enhanced laser desorption and ionization mass spectrometry profiles of the serum proteome. Chin J Cancer 29:721–728
Huang XW, Zhou W, Chen J et al (2011) A pilot investigation on serum protein fingerprinting of nasopharyngeal carcinoma. Chin J Otorhinolaryngol Head Neck Surg 46:509–512
Wei YS, Zheng YH, Liang WB et al (2008) Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis. Cancer 112:544–551
Wang Q, Li L, Li DR et al (2006) Identification of serum biomarkers for ovarian cancer using protein chips and time of flight mass spectrometry technology. Zhonghua Fu Chan Ke Za Zhi 41:544–548
Lim JY, Cho JY, Paik YH et al (2007) Diagnostic application of serum proteomic patterns in gastric cancer patients by ProteinChip surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Int J Biol Markers 22:281–286
Acknowledgments
The work was sponsored by the clinical research special foundation of Wu Jieping Medical Foundation (No.320.6750.06080), Guangxi Scientific Research and Technology Development Project (No.0719006-2-23), Guangxi Graduate Education and Innovation Project (No.2007105981002 M33), supplementary programs of Guangxi large instruments shared network test (No.533-2007-112) (No. 555-2007-134), major research projects of Guangxi universities (No. 201101ZD004), and the key project of Guangxi health care (No. 2011076). Xiao-dong Zhu and Fang Su contributed equally to this article. All authors read and approved the final manuscript.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
X. Zhu and F. Su were co-first authors.
About this article
Cite this article
Zhu, Xd., Su, F., Liang, Zg. et al. Identification of patients with nasopharyngeal carcinoma by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Int J Clin Oncol 19, 579–585 (2014). https://doi.org/10.1007/s10147-013-0621-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-013-0621-y